Posaconazole for the treatment of mucormycosis

International Journal of Antimicrobial Agents

Volumn 38, Issue 6, 2011, Pages 465-473

  Enoch, D A ^a   Aliyu, S H ^b   Sule, O ^b   Lewis, S J ^a   Karas, J A ^b  

^a PETERBOROUGH CITY HOSPITAL   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Antifungal agents; Mucormycosis; Posaconazole; Triazoles

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; ATAZANAVIR; CALCIUM CHANNEL BLOCKING AGENT; CASPOFUNGIN; CYCLOSPORIN; CYTOCHROME P450 3A4; DEFERASIROX; DIGOXIN; FLUCONAZOLE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN; ITRACONAZOLE; MICAFUNGIN; MIDAZOLAM; OXYGEN; PLACEBO; POSACONAZOLE; RAPAMYCIN; RIFABUTIN; SULFONYLUREA; TACROLIMUS; UNINDEXED DRUG; VINBLASTINE; VINCRISTINE; VORICONAZOLE;

ANTIFUNGAL ACTIVITY; ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; APOPHYSOMYCES; AREA UNDER THE CURVE; BROTH DILUTION; CASE STUDY; CUNNINGHAMELLA; DEBRIDEMENT; DISEASE MODEL; DRUG ANTAGONISM; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG DISTRIBUTION; DRUG DOSE COMPARISON; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MEGADOSE; DRUG MONITORING; DRUG POTENTIATION; EVIDENCE BASED MEDICINE; HUMAN; HYPERBARIC OXYGEN; LICHTHEIMIA; MINIMUM INHIBITORY CONCENTRATION; MUCOR; MUCORALES; MUCORMYCOSIS; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; QT PROLONGATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RHIZOMUCOR; RHIZOPUS; SURVIVAL RATE; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 80255126815     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2011.05.010     Document Type: Short Survey

References (98)

1. J.A. Ribes, C.L. Vanover-Sams, and D.J. Baker Zygomycetes in human disease Clin Microbiol Rev 13 2000 236 301 (Pubitemid 30205427)
2. M.M. Roden, T.E. Zaoutis, W.L. Buchanan, T.A. Knudsen, T.A. Sarkisova, and R.L. Schaufele Epidemiology and outcome of zygomycosis: a review of 929 reported cases Clin Infect Dis 41 2005 634 653 (Pubitemid 41170352)
3. D.S. Hibbett, M. Binder, J.F. Bischoff, M. Blackwell, P.F. Cannon, and O.E. Eriksson A higher-level phylogenetic classification of the Fungi Mycol Res 111 2007 509 547 (Pubitemid 46915419)
4. G.L. Petrikkos Lipid formulations of amphotericin B as first-line treatment of zygomycosis Clin Microbiol Infect 15 Suppl. 5 2009 87 92
5. V. Nagappan, and S. Deresinski Reviews of anti-infective agents: posaconazole: a broad-spectrum triazole antifungal agent Clin Infect Dis 45 2007 1610 1617 (Pubitemid 351411847)
6. A.S. Chau, G. Chen, P.M. McNicholas, and P.A. Mann Molecular basis for enhanced activity of posaconazole against Absidia corymbifera and Rhizopus oryzae Antimicrob Agents Chemother 50 2006 3917 3919 (Pubitemid 44684916)
7. C. Gil-Lamaignere, R. Hess, S. Salvenmoser, K. Heyn, R. Kappe, and F.M. Müller Effect of media composition and in vitro activity of posaconazole, caspofungin and voriconazole against zygomycetes J Antimicrob Chemother 55 2005 1016 1019 (Pubitemid 40883191)
8. C. Kuzucu, B. Rapino, L. McDermott, and S. Hadley Comparison of the semisolid agar antifungal susceptibility test with the NCCLS M38-P broth microdilution test for screening of filamentous fungi J Clin Microbiol 42 2004 1224 1227 (Pubitemid 38332852)
9. C. Antachopoulos, J. Meletiadis, E. Roilides, T. Sein, and T.J. Walsh Rapid susceptibility testing of medically important zygomycetes by XTT assay J Clin Microbiol 44 2006 553 560 (Pubitemid 43222251)
10. A. Espinel-Ingroff Comparison of three commercial assays and a modified disk diffusion assay with two broth microdilution reference assays for testing zygomycetes, Aspergillus spp., Candida spp., and Cryptococcus neoformans with posaconazole and amphotericin B J Clin Microbiol 44 2006 3616 3622 (Pubitemid 46768814)
11. M. Torres-Narbona, J. Guinea, J. Martínez-Alarcón, T. Peláez, and E. Bouza In vitro activities of amphotericin B, caspofungin, itraconazole, posaconazole, and voriconazole against 45 clinical isolates of zygomycetes: comparison of CLSI M38-A, Sensititre YeastOne, and the Etest Antimicrob Agents Chemother 51 2007 1126 1129 (Pubitemid 46355313)
12. A. Espinel-Ingroff, B. Arthington-Skaggs, N. Iqbal, D. Ellis, M.A. Pfaller, and S. Messer Multicenter evaluation of a new disk agar diffusion method for susceptibility testing of filamentous fungi with voriconazole, posaconazole, itraconazole, amphotericin B, and caspofungin J Clin Microbiol 45 2007 1811 1820 (Pubitemid 46933912)
13. A. Espinel-Ingroff, and E. Canton Comparison of Neo-Sensitabs tablet diffusion assay with CLSI broth microdilution M38-A and disk diffusion methods for testing susceptibility of filamentous fungi with amphotericin B, caspofungin, itraconazole, posaconazole, and voriconazole J Clin Microbiol 46 2008 1793 1803 (Pubitemid 351657231)
14. F. Marco, M.A. Pfaller, S.A. Messer, and R.N. Jones In vitro activity of a new triazole antifungal agent, Sch 56592, against clinical isolates of filamentous fungi Mycopathologia 141 1998 73 77 (Pubitemid 28407946)
15. M.A. Pfaller, S.A. Messer, R.J. Hollis, R.N. Jones, and SENTRY Participants Group Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000 Antimicrob Agents Chemother 46 2002 1032 1037 (Pubitemid 34260347)
16. Q.N. Sun, A.W. Fothergill, D.I. McCarthy, M.G. Rinaldi, and J.R. Graybill In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes Antimicrob Agents Chemother 46 2002 1581 1582 (Pubitemid 34415351)
17. E. Dannaoui, J. Meletiadis, J.W. Mouton, J.F. Meis, P.E. Verweij, and Eurofung Network In vitro susceptibilities of zygomycetes to conventional and new antifungals J Antimicrob Chemother 51 2003 45 52 (Pubitemid 36163826)
18. D.J. Diekema, S.A. Messer, R.J. Hollis, R.N. Jones, and M.A. Pfaller Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi J Clin Microbiol 41 2003 3623 3626 (Pubitemid 36994692)
19. F. Sabatelli, R. Patel, P.A. Mann, C.A. Mendrick, C.C. Norris, and R. Hare In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts Antimicrob Agents Chemother 50 2006 2009 2015 (Pubitemid 43807519)
20. R.N. Greenberg, K. Mullane, J.A. van Burik, I. Raad, M.J. Abzug, and G. Anstead Posaconazole as salvage therapy for zygomycosis Antimicrob Agents Chemother 50 2006 126 133 (Pubitemid 43042912)
21. N.G. Almyroudis, D.A. Sutton, A.W. Fothergill, M.G. Rinaldi, and S. Kusne In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents Antimicrob Agents Chemother 51 2007 2587 2590 (Pubitemid 47047341)
22. C. Lass-Flörl, A. Mayr, S. Perkhofer, G. Hinterberger, J. Hausdorfer, and C. Speth Activities of antifungal agents against yeasts and filamentous fungi: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing Antimicrob Agents Chemother 52 2008 3637 3641
23. S. Krishnan-Natesan, E.K. Manavathu, G.J. Alangaden, and P.H. Chandrasekar A comparison of the fungicidal activity of amphotericin B and posaconazole against zygomycetes in vitro Diagn Microbiol Infect Dis 63 2009 361 364
24. K. Uchida, N. Yokota, and H. Yamaguchi In vitro antifungal activity of posaconazole against various pathogenic fungi Int J Antimicrob Agents 18 2001 167 172 (Pubitemid 32757229)
25. M. Cuenca-Estrella, A. Gomez-Lopez, E. Mellado, M.J. Buitrago, A. Monzon, and J.L. Rodriguez-Tudela Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi Antimicrob Agents Chemother 50 2006 917 921 (Pubitemid 43327795)
26. F. Barchiesi, E. Spreghini, A. Santinelli, A.W. Fothergill, E. Pisa, and D. Giannini Posaconazole prophylaxis in experimental systemic zygomycosis Antimicrob Agents Chemother 51 2007 73 77 (Pubitemid 46047689)
27. S. Arikan, B. Sancak, S. Alp, G. Hascelik, and P. McNicholas Comparative in vitro activities of posaconazole, voriconazole, itraconazole, and amphotericin B against Aspergillus and Rhizopus, and synergy testing for Rhizopus Med Mycol 46 2008 567 573
28. A. Alastruey-Izquierdo, M.V. Castelli, I. Cuesta, A. Monzon, M. Cuenca-Estrella, and J.L. Rodriguez-Tudela Activity of posaconazole and other antifungal agents against Mucorales strains identified by sequencing of internal transcribed spacers Antimicrob Agents Chemother 53 2009 1686 1689
29. M.M. Rodríguez, F.J. Pastor, D.A. Sutton, E. Calvo, A.W. Fothergill, and V. Salas Correlation between in vitro activity of posaconazole and in vivo efficacy against Rhizopus oryzae infection in mice Antimicrob Agents Chemother 54 2010 1665 1669
30. E. Spreghini, F. Orlando, D. Giannini, and F. Barchiesi In vitro and in vivo activities of posaconazole against zygomycetes with various degrees of susceptibility J Antimicrob Chemother 65 2010 2158 2163
31. A. Espinel-Ingroff Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts J Clin Microbiol 36 1998 2950 2956 (Pubitemid 28429420)
32. G.M. González In vitro activities of isavuconazole against opportunistic filamentous and dimorphic fungi Med Mycol 47 2009 71 76
33. Z.U. Khan, S. Ahmad, A. Brazda, and R. Chandy Mucor circinelloides as a cause of invasive maxillofacial zygomycosis: an emerging dimorphic pathogen with reduced susceptibility to posaconazole J Clin Microbiol 47 2009 1244 1248
34. F.J. Pastor, M. Ruíz-Cendoya, I. Pujol, E. Mayayo, D.A. Sutton, and J. Guarro In vitro and in vivo antifungal susceptibilities of the Mucoralean fungus Cunninghamella Antimicrob Agents Chemother 54 2010 4550 4555
35. A. Chakrabarti, M.R. Shivaprakash, I. Curfs-Breuker, A. Baghela, C.H. Klaassen, and J.F. Meis Apophysomyces elegans: epidemiology, amplified fragment length polymorphism typing, and in vitro antifungal susceptibility pattern J Clin Microbiol 48 2010 4580 4585
36. Q.N. Sun, L.K. Najvar, R. Bocanegra, D. Loebenberg, and J.R. Graybill In vivo activity of posaconazole against Mucor spp. in an immunosuppressed-mouse model Antimicrob Agents Chemother 46 2002 2310 2312 (Pubitemid 34665939)
37. E. Dannaoui, J.F. Meis, D. Loebenberg, and P.E. Verweij Activity of posaconazole in treatment of experimental disseminated zygomycosis Antimicrob Agents Chemother 47 2003 3647 3650 (Pubitemid 37345740)
38. A.S. Ibrahim, T. Gebremariam, J.A. Schwartz, J.E. Edwards Jr., and B. Spellberg Posaconazole mono- or combination therapy for treatment of murine zygomycosis Antimicrob Agents Chemother 53 2009 772 775
39. J.A. van Burik, R.S. Hare, H.F. Solomon, M.L. Corrado, and D.P. Kontoyiannis Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases Clin Infect Dis 42 2006 e61 e65
40. J. Garbino, C. Myers, J. Ambrosioni, and F. Gumy-Pause Report of a successful treatment of pulmonary Cunninghamella bertholletiae infection with liposomal amphotericin and posaconazole in a child with GvHD and review of the literature J Pediatr Hematol Oncol 32 2010 85 87
41. A.M. Tobón, M. Arango, D. Fernández, and A. Restrepo Mucormycosis (zygomycosis) in a heart-kidney transplant recipient: recovery after posaconazole therapy Clin Infect Dis 36 2003 1488 1491 (Pubitemid 36702884)
42. I.I. Raad, J.R. Graybill, A.B. Bustamante, O.A. Cornely, V. Gaona-Flores, and C. Afif Safety of long-term oral posaconazole use in the treatment of refractory invasive fungal infections Clin Infect Dis 42 2006 1726 1734 (Pubitemid 43839438)
43. N. Singh, J.M. Aguado, H. Bonatti, G. Forrest, K.L. Gupta, and N. Safdar Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome J Infect Dis 200 2009 1002 1011
44. H.L. Leather, T.A. Correll, C.L. Meyer, I.M. Schmalfuss, and J.R. Wingard Treatment of zygomycosis with posaconazole in a patient with acute myeloid leukemia Clin Adv Hematol Oncol 3 2005 773 777 (Pubitemid 41782639)
45. G. Notheis, L. Tarani, F. Costantino, A. Jansson, J. Rosenecker, and D. Friederici Posaconazole for treatment of refractory invasive fungal disease Mycoses 49 Suppl. 1 2006 37 41 (Pubitemid 44370101)
46. T. Rutar, and K.P. Cockerham Periorbital zygomycosis (mucormycosis) treated with posaconazole Am J Ophthalmol 142 2006 187 188
47. A.L. Gilman, A. Serrano, J. Skelley, and D. Zwick Successful treatment of pulmonary zygomycosis with posaconazole in a recipient of a haploidentical donor stem cell transplant Pediatr Blood Cancer 47 2006 959 963 (Pubitemid 44656122)
48. D. Stark, S. Milliken, D. Marriott, and J. Harkness Rhizopus microsporus var. rhizopodiformis sinus-orbital zygomycosis in an immunosuppressed patient: successful treatment with posaconazole after a complicated clinical course J Med Microbiol 56 2007 699 701 (Pubitemid 46717499)
49. P. Sedlacek, V. Vavra, I. Masova, D. Codl, T. Laznickova, and L. Malaskova Successful therapy with ABLC, surgery and posaconazole for Rhizopus microsporus var. rhizopodiformis liver eumycetoma in a child with acute leukaemia Mycoses 52 2009 276 279
50. A.V. Page, A.J. Evans, L. Snell, and W.C. Liles Primary cutaneous mucormycosis in a lung transplant recipient: case report and concise review of the literature Transpl Infect Dis 10 2008 419 425
51. T. Peel, J. Daffy, K. Thursky, P. Stanley, and K. Buising Posaconazole as first line treatment for disseminated zygomycosis Mycoses 51 2008 542 545
52. O. Lebeau, C. Van Delden, J. Garbino, J. Robert, F. Lamoth, and J. Passweg Disseminated Rhizopus microsporus infection cured by salvage allogeneic hematopoietic stem cell transplantation, antifungal combination therapy, and surgical resection Transpl Infect Dis 12 2010 269 272
53. J.Y. Ting, S.Y. Chan, D.C. Lung, A.C. Ho, A.K. Chiang, and S.Y. Ha Intra-abdominal Rhizopus microsporus infection successfully treated by combined aggressive surgical, antifungal, and iron chelating therapy J Pediatr Hematol Oncol 32 2010 e238 e240
54. J. Kok, N. Gilroy, C. Halliday, O.C. Lee, D. Novakovic, and P. Kevin Early use of posaconazole in the successful treatment of rhino-orbital mucormycosis caused by Rhizopus oryzae J Infect 55 2007 e33 e36
55. T.A. Vyzantiadis, A. Kioumi, E. Papadakis, M. Braimi, E. Dermitzakis, and I. Tsitouridis Rhino-cerebral zygomycosis resistant to antimycotic treatment: a case report Mycoses 52 2009 87 90
56. K. Kulendra, M. Habibi, C. Butler, P. Clarke, and D. Howard Use of posaconazole in the treatment of infective rhinocerebral mucormycosis J Laryngol Otol 124 2010 1314 1317
57. M. Leithauser, C. Kahl, C. Aepinus, F. Prall, M. Maruschke, and H. Riemer Invasive zygomycosis in patients with graft-versus-host disease after allogeneic stem cell transplantation Transpl Infect Dis 12 2010 251 257
58. J.G. Wildenbeest, M.W. Oomen, R.J. Brüggemann, M. de Boer, Y. Bijleveld, and J.M. van den Berg Rhizopus oryzae skin infection treated with posaconazole in a boy with chronic granulomatous disease Pediatr Infect Dis J 29 2010 578
59. F. Palacio-Bedoya, J.A. Cadena, G.R. Thompson, D.A. Sutton, A.D. Owens, and T.F. Patterson A noninvasive renal fungus ball caused by Rhizopus-a previously unreported manifestation of zygomycosis Med Mycol 48 2010 866 869
60. O. Brugire, G. Dauriat, H. Mal, R. Marrash-Chalha, M. Fournier, and O. Groussard Pulmonary mucormycosis (zygomycosis) in a lung transplant recipient: recovery after posaconazole therapy Transplantation 80 2005 1361 1362
61. J. Garbino, I. Ukay, K. Amini, M. Puppo, M. Richter, and D. Lew Absidia posttraumatic infection: successful treatment with posaconazole J Infect 51 2005 e135 e138
62. J. Sörensen, M. Becker, L. Porto, E. Lambrecht, T. Schuster, and F. Beske Rhinocerebral zygomycosis in a young girl undergoing allogeneic stem cell transplantation for severe aplastic anaemia Mycoses 49 Suppl. 1 2006 31 36 (Pubitemid 44370100)
63. S. Lüer, S. Berger, M. Diepold, A. Duppenthaler, M. von Gunten, and K. Mühlethaler Treatment of intestinal and hepatic mucormycosis in an immunocompromized child Pediatr Blood Cancer 52 2009 872 874
64. M. Almaslamani, S.J. Taj-Aldeen, D. Garcia-Hermoso, E. Dannaoui, H. Alsoub, and A. Alkhal An increasing trend of cutaneous zygomycosis caused by Mycocladus corymbifer (formerly Absidia corymbifera): report of two cases and review of primary cutaneous Mycocladus infections Med Mycol 47 2009 532 538
65. B.G. Roux, F. Méchinaud, F. Gay-Andrieu, O. Lortholary, E. Dannaoui, and D. Hoinard Successful triple combination therapy of disseminated Absidia corymbifera infection in an adolescent with osteosarcoma J Pediatr Hematol Oncol 32 2010 131 133
66. J.H. Simmons, P.S. Zeitler, L.Z. Fenton, M.J. Abzug, R.V. Fiallo-Scharer, and G.J. Klingensmith Rhinocerebral mucormycosis complicated by internal carotid artery thrombosis in a pediatric patient with type 1 diabetes mellitus: a case report and review of the literature Pediatr Diabetes 6 2005 234 238 (Pubitemid 43013632)
67. C.D. Gelston, V.D. Durairaj, and E.A. Simoes Rhino-orbital mucormycosis causing cavernous sinus and internal carotid thrombosis treated with posaconazole Arch Ophthalmol 125 2007 848 849 (Pubitemid 46919754)
68. A.S. Harada, and W. Lau Successful treatment and limb salvage of Mucor necrotizing fasciitis after kidney transplantation with posaconazole Hawaii Med J 66 2007 68 71
69. R.L. Page 2nd, J. Schwiesow, and A. Hilts Posaconazole as salvage therapy in a patient with disseminated zygomycosis: case report and review of the literature Pharmacotherapy 27 2007 290 298 (Pubitemid 46214589)
70. M. Sedlacek, J.G. Cotter, A.A. Suriawinata, T.M. Kaneko, R.A. Zuckerman, and J. Parsonnet Mucormycosis peritonitis: more than 2 years of disease-free follow-up after posaconazole salvage therapy after failure of liposomal amphotericin B Am J Kidney Dis 51 2008 302 306
71. A. Azhar, O.V. Calubiran, R. Mohan Kilaru, J.A. Lincoln, I. Moshenyat, and K. Basti Patient with abdominal pain-concealing gastrointestinal mucormycosis Gastroenterol Hepatol (N Y) 5 2009 657 661
72. J.J. Mezhir, K.M. Mullane, J. Zarling, R. Satoskar, R.K. Pai, and K.K. Roggin Successful nonoperative management of gastrointestinal mucormycosis: novel therapy for invasive disease Surg Infect (Larchmt) 10 2009 447 451
73. V. Rickerts, J. Atta, S. Herrmann, V. Jacobi, E. Lambrecht, and R. Bialek Successful treatment of disseminated mucormycosis with a combination of liposomal amphotericin B and posaconazole in a patient with acute myeloid leukaemia Mycoses 49 Suppl. 1 2006 27 30 (Pubitemid 44370099)
74. M.M. Abuali, R. Posada, G. Del Toro, E. Roman, R. Ramani, and S. Chaturvedi Rhizomucor variabilis var. regularior and Hormographiella aspergillata infections in a leukemic bone marrow transplant recipient with refractory neutropenia J Clin Microbiol 47 2009 4176 4179
75. C. Nebel, K. Gersch, J.M. Smith, L.R. Rodersheimer, and S. Friedstrom Successful treatment of ascending aortic graft and valve endocarditis after debulking splenectomy for invasive aspergillosis and Mucor Am Surg 75 2009 1253 1255
76. A. Busca, F. Marmont, F. Locatelli, G. Limerutti, M.T. Sorrentino, and A. Barbui Combined antifungal therapy, iron chelation and surgical resection as treatment of hepatic zygomycosis in a patient with haematological malignancy Mycoses 53 2010 275 278
77. T.D. Ferguson, S.D. Schniederjan, J. Dionne-Odom, M.E. Brandt, M.G. Rinaldi, and F.S. Nolte Posaconazole treatment for Apophysomyces elegans rhino-orbital zygomycosis following trauma for a male with well-controlled diabetes J Clin Microbiol 45 2007 1648 1651 (Pubitemid 46762431)
78. P. Pitisuttithum, R. Negroni, J.R. Graybill, B. Bustamante, P. Pappas, and S. Chapman Activity of posaconazole in the treatment of central nervous system fungal infections J Antimicrob Chemother 56 2005 745 755 (Pubitemid 41487778)
79. S. Paul, F.M. Marty, and Y.L. Colson Treatment of cavitary pulmonary zygomycosis with surgical resection and posaconazole Ann Thorac Surg 82 2006 338 340
80. C.E. Margo, C. Linden, L.B. Strickland-Marmol, A.L. Denietolis, J.C. McCaffrey, and N. Kirk Rhinocerebral mucormycosis with perineural spread Ophthal Plast Reconstr Surg 23 2007 326 327 (Pubitemid 47220638)
81. F. Schlemmer, M. Lagrange-Xélot, C. Lacroix, R. de La Tour, G. Socié, and J.M. Molina Breakthrough Rhizopus infection on posaconazole prophylaxis following allogeneic stem cell transplantation Bone Marrow Transplant 42 2008 551 552
82. L.J. Lekakis, A. Lawson, J. Prante, J. Ribes, G.J. Davis, and G. Monohan Fatal Rhizopus pneumonia in allogeneic stem cell transplant patients despite posaconazole prophylaxis: two cases and review of the literature Biol Blood Marrow Transplant 15 2009 991 995
83. S. Mousset, G. Bug, W.J. Heinz, K. Tintelnot, and V. Rickerts Breakthrough zygomycosis on posaconazole prophylaxis after allogeneic stem cell transplantation Transpl Infect Dis 12 2010 261 264
84. T.J. Walsh, I. Raad, T.F. Patterson, P. Chandrasekar, G.R. Donowitz, and R. Graybill Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial Clin Infect Dis 44 2007 2 12 (Pubitemid 44968977)
85. G.R. Thompson 3rd, M.G. Rinaldi, G. Pennick, S.A. Dorsey, T.F. Patterson, and J.S. Lewis 2nd Posaconazole therapeutic drug monitoring: a reference laboratory experience Antimicrob Agents Chemother 53 2009 2223 2224
86. A.J. Ullmann, O.A. Cornely, A. Burchardt, R. Hachem, D.P. Kontoyiannis, and K. Töpelt Pharmacokinetics, safety, and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infection Antimicrob Agents Chemother 50 2006 658 666 (Pubitemid 43190980)
87. G. Krishna, M. Martinho, P. Chandrasekar, A.J. Ullmann, and H. Patino Pharmacokinetics of oral posaconazole in allogeneic hematopoietic stem cell transplant recipients with graft-versus-host disease Pharmacotherapy 27 2007 1627 1636 (Pubitemid 350234311)
88. W.W. Hope, E.M. Billaud, J. Lestner, and D.W. Denning Therapeutic drug monitoring for triazoles Curr Opin Infect Dis 21 2008 580 586
89. G. Krishna, A. Sansone-Parsons, M. Martinho, B. Kantesaria, and L. Pedicone Posaconazole plasma concentrations in juvenile patients with invasive fungal infection Antimicrob Agents Chemother 51 2007 812 818 (Pubitemid 46355260)
90. J.E. Conte Jr., C. DeVoe, E. Little, and J.A. Golden Steady-state intrapulmonary pharmacokinetics and pharmacodynamics of posaconazole in lung transplant recipients Antimicrob Agents Chemother 54 2010 3609 3613
91. F. Ezzet, D. Wexler, R. Courtney, G. Krishna, J. Lim, and M. Laughlin Oral bioavailability of posaconazole in fasted healthy subjects: comparison between three regimens and basis for clinical dosage recommendations Clin Pharmacokinet 44 2005 211 220 (Pubitemid 40188942)
92. A. Sansone-Parsons, G. Krishna, M. Martinho, B. Kantesaria, S. Gelone, and T.G. Mant Effect of oral posaconazole on the pharmacokinetics of cyclosporine and tacrolimus Pharmacotherapy 27 2007 825 834 (Pubitemid 46849426)
93. E. Dannaoui, P. Schwarz, and O. Lortholary In vitro interactions between antifungals and immunosuppressive drugs against zygomycetes Antimicrob Agents Chemother 53 2009 3549 3551
94. S. Narreddy, E. Manavathu, P.H. Chandrasekar, G.J. Alangaden, and S.G. Revankar In vitro interaction of posaconazole with calcineurin inhibitors and sirolimus against zygomycetes J Antimicrob Chemother 65 2010 701 703
95. M. Guembe, J. Guinea, T. Peláez, M. Torres-Narbona, and E. Bouza Synergistic effect of posaconazole and caspofungin against clinical zygomycetes Antimicrob Agents Chemother 51 2007 3457 3458 (Pubitemid 350067580)
96. G. Krishna, D. Vickery, L. Ma, X. Yu, C. Noren, and E. Power Lack of pharmacokinetic drug interaction between oral posaconazole and caspofungin or micafungin J Clin Pharmacol 51 2011 84 92
97. S. Perkhofer, M. Locher, M. Cuenca-Estrella, R. Rüchel, R. Würzner, and M.P. Dierich Posaconazole enhances the activity of amphotericin B against hyphae of zygomycetes in vitro Antimicrob Agents Chemother 52 2008 2636 2638 (Pubitemid 351915698)
98. F. Ballester, F.J. Pastor, and J. Guarro In vitro activities of combinations of amphotericin B, posaconazole and four other agents against Rhizopus J Antimicrob Chemother 61 2008 755 757 (Pubitemid 351321162)